Forum on Immunopathological Diseases and Therapeutics
Published/Hosted by Begell House Publishing Inc.
ISSN (printed): 2151-8017. ISSN (electronic): 2151-8025.
The aim of this journal is to serve as the publication vehicle for a workshop series which focuses on an important and timely gene product that is critical in the pathogenesis, progression and disease manifestation. Additionally, the gene product could serve as a potential biomarker for prognosis and diagnosis, and also as an object for therapeutic intervention and for development of novel specific and targeted therapeutics. The workshops cover topics that include biochemistry, immunology, molecular biology, genetics, molecular and cellular mechanisms of disease, clinical studies and new innovative therapies. A given workshop is highly focused and invited speakers are selected from active investigators who are leaders in the field of the topic of each workshop. The workshop consists of individualized sessions and each session is concluded with a discussion and expert opinions and recommendations made by other invited experts in light of current progress in the filed. This journal publishes the main presentations and expert opinions of each workshop in a special issue in the series. The authors of the articles (and workshop participants) are chosen from a small number of basic scientists and clinical investigators. As a result, each issue of the journal will deal with a particular subject. The manuscripts are reviewed in the usual manner by guest editors and by the series Editors. The special issue will be published no later than three months after final review by the series Editors. A major goal of the journal is to attain further integration of the various presentations and discussion topics.
- Further information
- Category Links